Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-02-28
2010-02-09
Prouty, Rebecca E. (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S078350, C514S059000, C536S051000, C436S086000
Reexamination Certificate
active
07659076
ABSTRACT:
Infective aggregating forms of proteins such as PrP, amyloid, and tau are bound selectively in the presence of the normal form protein using a polyionic binding agent such as dextran sulphate or pentosan (anionic), or polyamine compounds such as pDADMAC (cationic) under selective binding conditions including the use of n-lauroylsarcosine at mildly alkaline pH, and may then be assayed.
REFERENCES:
patent: 5216127 (1993-06-01), Hirai et al.
patent: 5846533 (1998-12-01), Prusiner et al.
patent: 5977324 (1999-11-01), Prusiner et al.
patent: 6221614 (2001-04-01), Prusiner et al.
patent: 6419916 (2002-07-01), Prusiner et al.
patent: 6916419 (2005-07-01), Prusiner et al.
patent: 7208281 (2007-04-01), Kiesewetter et al.
patent: 2002/0004586 (2002-01-01), Aguzzi et al.
patent: WO 0043782 (2000-07-01), None
Brimacombe et al. Chracterization and Polyanion-Binding of Purified Recombinant Prion Protein; Biochem. J., vol. 342, (1999) pp. 605-613.
Biondi et al. Abnormal Platelet Aggregation in Patients With Raynaud's Phenomenon; Journal of Clinical Pathology, vol. 42 (1989) pp. 716-718.
International Search Report for WO 03/073106 (Jan. 8, 2004).
Kongtawelert et al. “A Monoclonal antibody that recognizes 2,3-, 2,6- and 4,6-disulphate ester ring substitution in pyranose-containing polysaccharides”.Journal of Immunological Methods. 126 (1990) 39-49.
Serban et al. “Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins”Neurology. 40 (Jan. 1990) 110-117.
Fischer et al. “Binding of disease-associated prion protein to plasminogen”.Nature. 408 (Nov. 23, 2000) 479-483.
Brimacombe et al. “Characterization and polyanion-binding properties of purified recombinant prion protein”.Biochemical Society. 342 (1999) 605-613.
Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay, Alana M. Thackray, Lee Hopkins and Raymond Bujdoso Biochem J. (2007) 401, 475-483.
Eight prion strains have PrPScmolecules with different conformations, Jiri Safar, Holger Willie, Vincenza Itri, Darlene Groth, Hana Serban, Marilyn Torchia, Fred E. Cohen & Stanley B. Prusiner, Nature Medicine, vol. 4, No. 10, Oct. 1998 pp. 1157-1165.
Lane Amin R.
Stanley Christopher J.
Wilson Stuart M.
Martin Paul C.
Microsens Biophage Limited
Pillsbury Winthrop Shaw & Pittman LLP
Prouty Rebecca E.
LandOfFree
Binding of pathological forms of prion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding of pathological forms of prion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding of pathological forms of prion proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4161917